Clinical Trials Browser

Lymphoma, Waldenstrom Macroglobulinemia, Skin Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

NCT00866684 2025-03-14

PROSKIN

Phase 4 Terminated

44 enrolled 7 charts

Dermatologic

Skin Neoplasms

NCT04448873 2023-09-26

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

Phase 4 Completed

30 enrolled

Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome

NCT04077515 2023-01-30

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Phase 4 Completed

92 enrolled

Kaposiform Hemangioendothelioma, Hemangioma, Kasabach-Merritt Syndrome

NCT02688881 2022-06-15

Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors

Phase 4 Completed

6 enrolled

Other solid neoplasm

Refractory Solid Tumors

NCT03781050 2019-01-23

Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome

Phase 4 Unknown

10 enrolled

Hereditary Sensory and Autonomic Neuropathies, Peutz-Jeghers Syndrome

NCT03500367 2018-04-18

Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis

Phase 4 Unknown

25 enrolled

Leiomyoma

NCT01797315 2017-05-04

PROSKIN

Phase 4 Terminated

40 enrolled

Dermatologic

Renal Transplant Patients at High-risk for Skin Cancer

NCT00129961 2012-04-11

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Phase 4 Completed

86 enrolled 22 charts

Dermatologic

Skin Neoplasms

NCT01217125 2012-03-08

Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis

Phase 4 Completed

18 enrolled

Angiomyolipoma

Clinical Trials

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

PROSKIN

Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors

Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome

Efficacy and Safety of Rapamycin (Sirolimus) in the Treatment of Symptomatic Uterine Fibroids and Leiomyomatosis

PROSKIN

Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis